Novo Nordisk's closely watched Alzheimer's trials of an older oral version of its semaglutide drug failed to help slow the ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

Novo Nordisk announced on Monday that it is lowering costs for weight loss and diabetes drugs, weeks after it struck a deal ...

Meghan Trainor’s weight loss journey began with a health scare during pregnancy. “I’m getting a lot of hate online just ...

Women who have rebound weight gain after stopping Wegovy or similar jabs end up gaining more weight during pregnancy, leading ...

Why Am I Not Losing Weight on Wegovy®? How to Get Results Key takeaways: Not losing weight on Wegovy® could be due to dose, ...

Novo Nordisk plans “all in” launch of Wegovy pill in the US market and will cut price of the drug's injectable option in the ...

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill, as the firm races to claw back lost ...

Danish pharma major Novo Nordisk has slashed the price of Wegovy by up to 37%, to take on its key rival Eli Lilly. Here's how ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...